GlakoLens

About:

Spin-off start-up developing contact lens based continuous monitoring solutions for ocular hypertension and glaucoma management.

Website: https://glakolens.com/

Top Investors: ACT Venture Partners

Description:

Glakolens is a Turkey-based developer of contact lens based biosensor technologies. The company offers non-invasive, continuous monitoring solutions for ocular hypertension and glaucoma management.

Total Funding Amount:

465000 EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Istanbul, Istanbul, Turkey

Founded Date:

2017-02-01

Contact Email:

info(AT)glakolens.com

Founders:

Arda Deniz Yalcinkaya, Günhan Dündar, Hamdi Torun

Number of Employees:

1-10

Last Funding Date:

2017-05-25

IPO Status:

Private

Industries: